ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG EFFECT;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
INFRARED RADIATION;
MASS SPECTROMETRY;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
SUBSTITUTION REACTION;
VASCULAR RING;
VASODILATATION;
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H- 2,6-dioxa-4-azacyclopenta[b]naphtalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener
10.1021/jm060549u
RJ Altenbach ME Brune SA Buckner MJ Coghlan AV Daza A Fabiyi 2006 Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphtalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener J Med Chem 49 6869 6887 10.1021/jm060549u
Vasorelaxing properties of some phenylacridine type potassium channel openers in isolated rabbit thoracic arteries
10.1016/S0223-5234(02)01374-0
O Berkan B Saraç R Şimşek S YIldIrIm Y SarIoǧlu C Şafak 2002 Vasorelaxing properties of some phenylacridine type potassium channel openers in isolated rabbit thoracic arteries Eur J Med Chem 37 519 523 10.1016/S0223-5234(02)01374-0
(-)-(9S)-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno [3,2-b] quinoline-8(4H)-one 1,1-dioxide (A-278637): A novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization
10.1124/jpet.102.034553
ME Brune TA Fey JD Brioni JP Sullivan M Williams WA Carroll 2002 (-)-(9S)-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno [3,2-b] quinoline-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. In vivo characterization J Pharmacol Exp Ther 303 1 387 394 10.1124/jpet.102.034553
ATP-sensitive potassium channel: A novel target for protection against UV-induced human skin cell damage
10.1002/jcp.21026
C Cao S Healey A Amaral A Lee-Couture S Wan N Kouttab 2007 ATP-sensitive potassium channel: a novel target for protection against UV-induced human skin cell damage J Cell Physiol 212 1 252 263 10.1002/jcp.21026
Opening of potassium channels protects mitochondrial function from calcium overload
10.1006/jsre.2000.5979
JA Crestanello NM Doliba AM Babsky NM Debliba K Niiobori MD Osbakken 2000 Opening of potassium channels protects mitochondrial function from calcium overload J Surg Res 94 16 23 10.1006/jsre.2000.5979
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: Characterization and pharmacology of binding
10.1124/mol.64.1.143
R Davis-Taber EJ Molinari RJ Altenbach KL Whiteaker C Shieh G Rotert 2003 [125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: Characterization and pharmacology of binding Mol Pharm 64 1 143 153 10.1124/mol.64.1.143
Role of potassium channels in regulation of brain arteriolar tone: Comparison of cerebrum versus brain stem
T Horiuchi HH Dietrich S Tsugane RGS Dacey 2001 Role of potassium channels in regulation of brain arteriolar tone: comparison of cerebrum versus brain stem Stroke 32 218 224
ATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)- acridinedione in bladder detrusor in vitro
ATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)-acridinedione in bladder detrusor in vitro Arzneim Forsch 46 5 525 530
Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels
Y Liu G Ren B Rourke E Marban J Seharaseyon 2001 Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels Mol Pharmacol 59 225 230
Some arylacridine derivatives possessing potassium channel opening activity
10.1016/j.farmac.2004.07.011
R Şimşek M Ozkan E KIsmetli S Uma C Şafak 2004 Some arylacridine derivatives possessing potassium channel opening activity Farmaco 59 939 943 10.1016/j.farmac.2004.07.011
K-channel opening activity of dihydropyridine ZM244085: Effect on 86Rb efflux and 3H-P1075 binding in urinary bladder smooth muscle
S Trivedi L Potter-Lee MW McConville JH Li CJ Ohnmacht DA Trainor 1995 K-channel opening activity of dihydropyridine ZM244085: effect on 86Rb efflux and 3H-P1075 binding in urinary bladder smooth muscle Res Commun Mol Pathol Pharmacol 88 2 137 151
ATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)- acridinedione in bladder detrusor in vitro
10.1016/S0022-5347(01)63369-X
ATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8- (2H,5H)-acridinedione in bladder detrusor in vitro J Urol 159 6 2264 10.1016/S0022-5347(01)63369-X
Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB
10.1126/science.2122520
WN Zagotta T Hoshi RW Aldrich 1990 Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB Science 250 568 571 10.1126/science.2122520